285 related articles for article (PubMed ID: 23046991)
1. Characterization of enterovirus 71 capsids using subunit protein-specific polyclonal antibodies.
Liu Q; Huang X; Ku Z; Wang T; Liu F; Cai Y; Li D; Leng Q; Huang Z
J Virol Methods; 2013 Jan; 187(1):127-31. PubMed ID: 23046991
[TBL] [Abstract][Full Text] [Related]
2. Detection, characterization and quantitation of coxsackievirus A16 using polyclonal antibodies against recombinant capsid subunit proteins.
Liu Q; Ku Z; Cai Y; Sun B; Leng Q; Huang Z
J Virol Methods; 2011 Apr; 173(1):115-20. PubMed ID: 21295614
[TBL] [Abstract][Full Text] [Related]
3. Determination of the cleavage site of enterovirus 71 VP0 and the effect of this cleavage on viral infectivity and assembly.
Cao J; Liu H; Qu M; Hou A; Zhou Y; Sun B; Cai L; Gao F; Su W; Jiang C
Microb Pathog; 2019 Sep; 134():103568. PubMed ID: 31195113
[TBL] [Abstract][Full Text] [Related]
4. Mutations in VP2 and VP1 capsid proteins increase infectivity and mouse lethality of enterovirus 71 by virus binding and RNA accumulation enhancement.
Huang SW; Wang YF; Yu CK; Su IJ; Wang JR
Virology; 2012 Jan; 422(1):132-43. PubMed ID: 22078110
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of a cross-neutralization epitope of Enterovirus 71.
Liu CC; Chou AH; Lien SP; Lin HY; Liu SJ; Chang JY; Guo MS; Chow YH; Yang WS; Chang KH; Sia C; Chong P
Vaccine; 2011 Jun; 29(26):4362-72. PubMed ID: 21501643
[TBL] [Abstract][Full Text] [Related]
6. Partial protection against enterovirus 71 (EV71) infection in a mouse model immunized with recombinant Newcastle disease virus capsids displaying the EV71 VP1 fragment.
Ch'ng WC; Stanbridge EJ; Ong KC; Wong KT; Yusoff K; Shafee N
J Med Virol; 2011 Oct; 83(10):1783-91. PubMed ID: 21837796
[TBL] [Abstract][Full Text] [Related]
7. The VP1 structural protein of enterovirus 71 interacts with human ornithine decarboxylase and gene trap ankyrin repeat.
Yeo WM; Chow VT
Microb Pathog; 2007 Apr; 42(4):129-37. PubMed ID: 17276651
[TBL] [Abstract][Full Text] [Related]
8. Structure, Immunogenicity, and Protective Mechanism of an Engineered Enterovirus 71-Like Particle Vaccine Mimicking 80S Empty Capsid.
Wang X; Ku Z; Zhang X; Ye X; Chen J; Liu Q; Zhang W; Zhang C; Fu Z; Jin X; Cong Y; Huang Z
J Virol; 2018 Jan; 92(1):. PubMed ID: 29070691
[TBL] [Abstract][Full Text] [Related]
9. Identification of Positively Charged Residues in Enterovirus 71 Capsid Protein VP1 Essential for Production of Infectious Particles.
Yuan S; Li G; Wang Y; Gao Q; Wang Y; Cui R; Altmeyer R; Zou G
J Virol; 2016 Jan; 90(2):741-52. PubMed ID: 26512078
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a novel monoclonal antibody reactive against the N-terminal region of Enterovirus 71 VP1 capsid protein.
Lim XF; Jia Q; Chow VT; Kwang J
J Virol Methods; 2013 Mar; 188(1-2):76-82. PubMed ID: 23219932
[TBL] [Abstract][Full Text] [Related]
11. Expression and immunogenicity of novel subunit enterovirus 71 VP1 antigens.
Xu J; Wang S; Gan W; Zhang W; Ju L; Huang Z; Lu S
Biochem Biophys Res Commun; 2012 Apr; 420(4):755-61. PubMed ID: 22450314
[TBL] [Abstract][Full Text] [Related]
12. [Expression and activity determination of recombinant capsid protein VP2 gene of enterovirus type 71].
Huang X; Liu G; Hu X; Du Y; Li X; Xu Y; Chen H; Xu B
Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Apr; 48(4):324-7. PubMed ID: 24969459
[TBL] [Abstract][Full Text] [Related]
13. Development of murine monoclonal antibodies with potent neutralization effects on enterovirus 71.
Ku Z; Shi J; Liu Q; Huang Z
J Virol Methods; 2012 Dec; 186(1-2):193-7. PubMed ID: 22771741
[TBL] [Abstract][Full Text] [Related]
14. VP2 dominated CD4+ T cell responses against enterovirus 71 and cross-reactivity against coxsackievirus A16 and polioviruses in a healthy population.
Tan S; Tan X; Sun X; Lu G; Chen CC; Yan J; Liu J; Xu W; Gao GF
J Immunol; 2013 Aug; 191(4):1637-47. PubMed ID: 23863902
[TBL] [Abstract][Full Text] [Related]
15. Identification and production of mouse scFv to specific epitope of enterovirus-71 virion protein-2 (VP2).
Thanongsaksrikul J; Srimanote P; Tongtawe P; Glab-Ampai K; Malik AA; Supasorn O; Chiawwit P; Poovorawan Y; Chaicumpa W
Arch Virol; 2018 May; 163(5):1141-1152. PubMed ID: 29356992
[TBL] [Abstract][Full Text] [Related]
16. [Study on the association of hand, foot and mouth disease and enterovirus 71/CA16 among children in Beijing, 2007].
Zhu RN; Qian Y; Deng J; Xing JF; Zhao LQ; Wang F; Liao B; Ren XX; Li Y; Zhang Q; Li J
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):1004-8. PubMed ID: 18399150
[TBL] [Abstract][Full Text] [Related]
17. [Expression of recombinant VP1 protein of enterovirus 71 and development of serological assay for detection of EV71 infection].
Zhou BP; Liu WL; Xie JJ; Chen XC; Xu LM; Tan Y; Liu YX; Yang GL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Dec; 22(6):492-4. PubMed ID: 19544656
[TBL] [Abstract][Full Text] [Related]
18. Display of enterovirus 71 VP1 on baculovirus as a type II transmembrane protein elicits protective B and T cell responses in immunized mice.
Kolpe AB; Kiener TK; Grotenbreg GM; Kwang J
Virus Res; 2012 Sep; 168(1-2):64-72. PubMed ID: 22728446
[TBL] [Abstract][Full Text] [Related]
19. Purification and characterization of enterovirus 71 viral particles produced from vero cells grown in a serum-free microcarrier bioreactor system.
Liu CC; Guo MS; Lin FH; Hsiao KN; Chang KH; Chou AH; Wang YC; Chen YC; Yang CS; Chong PC
PLoS One; 2011; 6(5):e20005. PubMed ID: 21603631
[TBL] [Abstract][Full Text] [Related]
20. Determinants of EV71 immunogenicity and protection against lethal challenge in a mouse model.
Chang J; Li J; Wei W; Liu X; Liu G; Yang J; Zhang W; Yu XF
Immunol Res; 2015 Jul; 62(3):306-15. PubMed ID: 26025091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
